Paul J Clancy Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Paul J Clancy.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Paul J Clancy. Paul J Clancy is Director in INCYTE CORP ($INCY) and EVP, Chief Financial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and CFO in BIOGEN INC. ($IDPH) and Executive VP and CFO in BIOGEN INC. ($IDPH) and Director in EXACT SCIENCES CORP ($EXAS) and Director in AGIOS PHARMACEUTICALS INC ($AGIO).

Latest Insider Trading Transactions of Paul J Clancy

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGIO, ALXN, IDPH, EXAS, INCY

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 01 2021	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	81.27	298	24,218	5,094	4.8 K to 5.1 K (+6.21 %)
Mar 19 2021	EXAS	EXACT SCIENCES COR ...	Clancy Paul J	Director	Grant	A	0.00	2,929	0	2,929	0 to 2.9 K
Oct 01 2020	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	89.74	260	23,332	4,515	4.3 K to 4.5 K (+6.11 %)
Jul 01 2020	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	103.97	229	23,809	4,255	4 K to 4.3 K (+5.69 %)
Jun 01 2020	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	M	0.00	1,878	0	0
Jun 01 2020	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	0.00	1,686	0	1,686
Jun 01 2020	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	53.35	8,096	431,922	8,096
Jun 01 2020	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Buy	M	0.00	1,878	0	3,278	1.4 K to 3.3 K (+134.14 %)
May 28 2020	INCY	INCYTE CORP	Clancy Paul J	Director	Option Exercise	A	98.68	10,514	1,037,522	10,514
May 28 2020	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	0.00	1,282	0	4,026	2.7 K to 4 K (+46.72 %)
Apr 02 2020	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	73.23	287	21,017	2,744	2.5 K to 2.7 K (+11.68 %)
Oct 02 2019	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	74.23	266	19,745	2,226	2 K to 2.2 K (+13.57 %)
Jul 15 2019	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Payment of Exercise	F	124.20	5,230	649,566	90,447	95.7 K to 90.4 K (-5.47 %)
Apr 29 2019	INCY	INCYTE CORP	Clancy Paul J	Director	Option Exercise	A	75.03	12,472	935,774	12,472
Apr 29 2019	INCY	INCYTE CORP	Clancy Paul J	Director	Grant	A	0.00	1,520	0	1,723	203 to 1.7 K (+748.77 %)
Mar 05 2019	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Grant	A	0.00	9,428	0	95,677	86.2 K to 95.7 K (+10.93 %)
Mar 04 2019	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Payment of Exercise	F	132.93	1,079	143,431	86,249	87.3 K to 86.2 K (-1.24 %)
Feb 11 2019	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Payment of Exercise	F	119.57	5,981	715,148	87,328	93.3 K to 87.3 K (-6.41 %)
Jul 12 2018	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Sell	S	131.11	5,241	687,148	93,309	98.6 K to 93.3 K (-5.32 %)
Jun 04 2018	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	0.00	1,400	0	1,400
Jun 04 2018	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	93.50	5,700	532,950	5,700
May 03 2018	INCY	INCYTE CORP	Clancy Paul J	Director	Option Exercise	A	60.85	15,000	912,750	15,000
Feb 08 2018	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Sell	S	116.31	6,079	707,048	89,014	95.1 K to 89 K (-6.39 %)
Feb 08 2018	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Grant	A	0.00	48,228	0	95,093	46.9 K to 95.1 K (+102.91 %)
Jul 12 2017	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Option Exercise	A	123.76	29,089	3,600,055	29,089
Jul 12 2017	ALXN	ALEXION PHARMACEUT ...	Clancy Paul J	EVP, Chief Financia ...	Grant	A	0.00	46,865	0	46,865	0 to 46.9 K
Jun 15 2017	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	50.73	9,000	456,570	9,000
May 31 2017	INCY	INCYTE CORP	Clancy Paul J	Director	Option Exercise	A	134.38	15,000	2,015,700	15,000
Apr 27 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Sell	S	290.00	9,892	2,868,680	10,813	20.7 K to 10.8 K (-47.78 %)
Mar 14 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Sell	S	291.55	9,891	2,883,721	20,705	30.6 K to 20.7 K (-32.33 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	2,873	0	0
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	1,152	0	0
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	2,092	0	7,546
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	663	0	1,774
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	J	0.00	1,105	0	2,437
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	J	0.00	1,678	0	9,638
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	J	0.00	1,352	0	1,152
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	274.76	1,352	371,476	30,596	31.9 K to 30.6 K (-4.23 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	2,873	0	31,948	29.1 K to 31.9 K (+9.88 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	274.76	543	149,195	29,075	29.6 K to 29.1 K (-1.83 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	1,152	0	29,618	28.5 K to 29.6 K (+4.05 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	287.63	847	243,623	28,466	29.3 K to 28.5 K (-2.89 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	2,092	0	29,313	27.2 K to 29.3 K (+7.69 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	284.75	312	88,842	27,221	27.5 K to 27.2 K (-1.13 %)
Mar 02 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	663	0	27,533	26.9 K to 27.5 K (+2.47 %)
Feb 17 2017	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	A	0.00	7,650	0	7,650
Jun 23 2016	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	47.33	9,000	425,970	58,400
May 31 2016	INCY	INCYTE CORP	Clancy Paul J	Director	Option Exercise	A	84.53	15,000	1,267,950	15,000
Feb 25 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	J	0.00	1,149	0	3,462
Feb 25 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	579	0	4,611
Feb 25 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	258.99	273	70,704	26,870	27.1 K to 26.9 K (-1.01 %)
Feb 25 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	579	0	27,143	26.6 K to 27.1 K (+2.18 %)
Feb 24 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	A	0.00	11,060	0	11,060
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	J	0.00	1,394	0	2,448
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	2,807	0	2,808
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	1,052	0	3,842
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	247.22	1,204	297,653	26,564	27.8 K to 26.6 K (-4.34 %)
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	2,807	0	27,768	25 K to 27.8 K (+11.25 %)
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	247.22	495	122,374	24,961	25.5 K to 25 K (-1.94 %)
Feb 17 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	1,052	0	25,456	24.4 K to 25.5 K (+4.31 %)
Feb 09 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	M	0.00	3,194	0	0
Feb 09 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	250.77	1,047	262,556	24,404	25.5 K to 24.4 K (-4.11 %)
Feb 09 2016	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Buy	M	0.00	3,194	0	25,451	22.3 K to 25.5 K (+14.35 %)
Jun 25 2015	AGIO	AGIOS PHARMACEUTIC ...	Clancy Paul J	Director	Option Exercise	A	103.63	11,900	1,233,197	49,400
May 27 2015	INCY	INCYTE CORP	Clancy Paul J	Director	Option Exercise	A	107.69	15,000	1,615,350	15,000
Feb 25 2015	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	A	0.00	5,190	0	5,190
Jun 03 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	47.22	1,253	59,167	47,732	49 K to 47.7 K (-2.56 %)
Feb 25 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	A	0.00	17,123	0	17,123
Feb 25 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	55.29	1,066	58,939	48,985	50.1 K to 49 K (-2.13 %)
Feb 25 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	55.29	1,056	58,386	50,051	51.1 K to 50.1 K (-2.07 %)
Feb 25 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Grant	A	0.00	9,970	0	51,107	41.1 K to 51.1 K (+24.24 %)
Feb 17 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	55.21	1,661	91,704	41,137	42.8 K to 41.1 K (-3.88 %)
Feb 17 2010	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	55.21	793	43,782	42,798	43.6 K to 42.8 K (-1.82 %)
Sep 08 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	51.01	1,114	56,825	43,591	44.7 K to 43.6 K (-2.49 %)
Aug 03 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	47.55	348	16,547	44,705	45.1 K to 44.7 K (-0.77 %)
Aug 03 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	47.55	835	39,704	45,053	45.9 K to 45.1 K (-1.82 %)
Jun 03 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	50.90	1,253	63,778	45,888	47.1 K to 45.9 K (-2.66 %)
Feb 26 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Option Exercise	A	49.65	26,785	1,329,875	26,785
Feb 26 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Grant	A	0.00	10,070	0	47,141	37.1 K to 47.1 K (+27.16 %)
Feb 17 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	52.61	1,661	87,385	35,410	37.1 K to 35.4 K (-4.48 %)
Feb 17 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	52.61	741	38,984	37,071	37.8 K to 37.1 K (-1.96 %)
Feb 10 2009	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	52.48	529	27,762	39,473	40 K to 39.5 K (-1.32 %)
Sep 23 2008	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Sell	S	50.00	1,553	77,650	40,002	41.6 K to 40 K (-3.74 %)
Sep 08 2008	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Payment of Exercise	F	48.16	1,114	53,650	41,555	42.7 K to 41.6 K (-2.61 %)
Aug 11 2008	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Sell	S	50.67	200	10,134	42,669	42.9 K to 42.7 K (-0.47 %)
Aug 11 2008	IDPH	BIOGEN INC.	Clancy Paul J	Executive VP and CF ...	Sell	S	50.66	368	18,643	42,869	43.2 K to 42.9 K (-0.85 %)
Aug 05 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Grant	A	0.00	6,000	0	43,237	37.2 K to 43.2 K (+16.11 %)
Aug 05 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Payment of Exercise	F	50.01	265	13,253	37,237	37.5 K to 37.2 K (-0.71 %)
Jul 02 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	56.01	4,208	235,679	37,502	41.7 K to 37.5 K (-10.09 %)
Jun 02 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Payment of Exercise	F	62.75	953	59,801	41,710	42.7 K to 41.7 K (-2.23 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.89	100	6,089	42,663	42.8 K to 42.7 K (-0.23 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.62	100	6,062	42,763	42.9 K to 42.8 K (-0.23 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.47	100	6,047	42,863	43 K to 42.9 K (-0.23 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.22	100	6,022	42,963	43.1 K to 43 K (-0.23 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.20	483	29,077	43,063	43.5 K to 43.1 K (-1.11 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.15	400	24,060	43,546	43.9 K to 43.5 K (-0.91 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.14	100	6,014	43,946	44 K to 43.9 K (-0.23 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.13	600	36,078	44,046	44.6 K to 44 K (-1.34 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.07	100	6,007	44,646	44.7 K to 44.6 K (-0.22 %)
Feb 22 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.05	100	6,005	44,746	44.8 K to 44.7 K (-0.22 %)
Feb 19 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Payment of Exercise	F	62.20	1,017	63,257	44,846	45.9 K to 44.8 K (-2.22 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Option Exercise	A	60.56	43,940	2,661,006	43,940
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.82	58	3,528	30,173	30.2 K to 30.2 K (-0.19 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.88	200	12,176	30,231	30.4 K to 30.2 K (-0.66 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.99	100	6,099	30,431	30.5 K to 30.4 K (-0.33 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.76	200	12,152	30,531	30.7 K to 30.5 K (-0.65 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	61.25	100	6,125	30,731	30.8 K to 30.7 K (-0.32 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	61.29	100	6,129	30,831	30.9 K to 30.8 K (-0.32 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Sell	S	60.94	200	12,188	30,931	31.1 K to 30.9 K (-0.64 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Grant	A	0.00	15,690	0	45,863	30.2 K to 45.9 K (+52.00 %)
Feb 14 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Payment of Exercise	F	60.56	742	44,936	31,131	31.9 K to 31.1 K (-2.33 %)
Feb 07 2008	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Payment of Exercise	F	60.52	522	31,591	31,873	32.4 K to 31.9 K (-1.61 %)
Sep 05 2007	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Option Exercise	A	63.55	20,000	1,271,000	20,000
Sep 05 2007	IDPH	BIOGEN INC.	Clancy Paul J	CFO	Grant	A	0.00	8,000	0	32,395	24.4 K to 32.4 K (+32.79 %)

Page: 1